Institute of Biomedical Research Corp. (MRES)
USD 0.01
(-26.32%)
USD 0.01
(-26.32%)
| Breakdown | 2010 | 2009 | 2008 | 2007 | 2006 | 2004 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -231.77 Thousand | -406.61 Thousand | -98.25 Thousand | -23.27 Thousand | -154.86 Thousand | -23.27 Thousand |
| Net Income | -273.4 Thousand | -443.28 Thousand | -5.36 Million | -690.3 Thousand | -176.88 Thousand | -20.14 Thousand |
| Depreciation & Amortization | 22.57 Thousand | 28.01 Thousand | 11.28 Thousand | - | 713.00 | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 16.71 Thousand | 8657.00 | -25 Thousand | 18.18 Thousand | -16.76 Thousand | -3136.00 |
| Other non-cash items | 2336.00 | - | 5.28 Million | 648.83 Thousand | 38.06 Thousand | - |
| Investing Cash Flow | -23.65 Thousand | -7303.00 | -107.26 Thousand | - | - | - |
| Investments in PPE | -7500.00 | -7303.00 | -107.26 Thousand | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -16.15 Thousand | - | - | - | - | - |
| Financing Cash Flow | 255.42 Thousand | 413.92 Thousand | 205.52 Thousand | 23.27 Thousand | 105.76 Thousand | 23.27 Thousand |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | 17.3 Thousand | 10.87 Thousand | - | - | - |
| Other Financing Activities | 255.42 Thousand | 396.61 Thousand | 194.65 Thousand | 23.27 Thousand | 105.76 Thousand | 23.27 Thousand |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | - | - | -25 Thousand | 18.18 Thousand | - | - |
| Cash at beginning of period | - | - | - | - | 49.09 Thousand | - |
| Cash at end of period | - | - | - | - | -4.00 | - |
| Capital Expenditure | -7500.00 | -7303.00 | -107.26 Thousand | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | - | - | - | - | -49.1 Thousand | - |
| Free Cash Flow | -239.27 Thousand | -413.92 Thousand | -205.52 Thousand | -23.27 Thousand | -154.86 Thousand | -23.27 Thousand |
| Breakdown | 2010 Q4 | 2010 Q3 | 2010 Q2 | 2010 FY | 2010 Q1 | 2009 Q4 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -55.68 Thousand | -76.91 Thousand | -50.08 Million | -273.4 Thousand | -118.58 Thousand | -102.03 Thousand |
| Depreciation & Amortization | - | - | 51.67 Million | 22.57 Thousand | 6753.00 | 5699.00 |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 37.57 Thousand | 40.96 Thousand | 11.01 Thousand | 16.71 Thousand | 17.38 Thousand | -1586.00 |
| Other non-cash items | 12.93 Thousand | 12.93 Thousand | -1.63 Million | 2336.00 | 2336.00 | - |
| Investing Cash Flow | - | - | - | -23.65 Thousand | -8458.00 | -15.19 Thousand |
| Investments in PPE | - | - | - | -7500.00 | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | -16.15 Thousand | - | - |
| Financing Cash Flow | 5181.00 | 23.02 Thousand | 31.27 Thousand | 255.42 Thousand | 100.57 Thousand | 113.11 Thousand |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | - | 255.42 Thousand | 100.57 Thousand | 113.11 Thousand |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | - | - | - | - | - | - |
| Cash at end of period | - | - | - | - | - | - |
| Capital Expenditure | - | - | - | -7500.00 | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | - | - | - | - | - | - |
| Free Cash Flow | -5181.00 | -23.02 Thousand | -31.27 Thousand | -239.27 Thousand | -92.11 Thousand | -97.91 Thousand |
PTKFF
002826
JMJFIN
2120
SSRM
FRONTCORP